Meeting
2020 ASCO Virtual Scientific Program
Impact of SWI/SNF complex mutations in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors: Immuno-oncology biomarker study in LC-SCRUM-Japan (LC-SCRUM-IBIS).
Presenter
Kiyotaka Yoh, MD
National Cancer Center Hospital East
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9530)
DOI
10.1200/JCO.2020.38.15_suppl.9530
Abstract #
9530
Poster Bd #
296
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2014 ASCO Annual Meeting
Updates in Immunotherapy: (PD-1 Checkpoint Inhibitor) Trials in Non-Small Cell Lung Cancer
Speaker: Laura Quan Man Chow, MD, FRCPC
Videos & Slides
2024 ASCO Annual Meeting
Artificial intelligence (AI) -powered H&E whole-slide image (WSI) analysis of tertiary lymphoid structure (TLS) to predict response to immunotherapy in non-small cell lung cancer (NSCLC).
Speaker: Leeseul Kim, MD
Videos & Slides
2024 ASCO Annual Meeting
Cost analysis of targeted and immunotherapies in operable esophageal and non-small cell lung cancers.
Speaker: Yahya Alwatari, MBBS
Videos & Slides
2023 ASCO Annual Meeting
Surgical outcomes of patients with resectable non-small-cell lung cancer receiving neoadjuvant immunotherapy with nivolumab plus relatlimab or nivolumab: Findings from the prospective, randomized, multicentric phase II study NEOpredict-Lung.
Speaker: Clemens Aigner, MD, MBA